NASDAQ: AZN
Astrazeneca PLC Stock Ownership - Who owns Astrazeneca?

Insider buying vs selling

Have Astrazeneca PLC insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when AZN insiders and whales buy or sell their stock.

AZN Shareholders

What type of owners hold Astrazeneca PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Price T Rowe Associates Inc3.68%57,086,881$4.06BInstitution
Primecap Management Co2.62%40,661,485$2.89BInstitution
Wellington Management Group LLP2.30%35,630,680$2.53BInstitution
Bank Of America Corp2.05%31,833,015$2.26BInstitution
Capital International Investors2.02%31,285,560$2.23BInstitution
Fmr LLC1.49%23,092,471$1.64BInstitution
Franklin Resources Inc1.36%21,101,993$1.50BInstitution
Fisher Asset Management LLC1.30%20,165,459$1.43BInstitution
Morgan Stanley1.02%15,768,536$1.12BInstitution
Sanders Capital LLC0.97%15,068,986$1.07BInstitution

1 of 3

AZN vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AZN32.60%0.00%
MRK77.19%0.22%Net BuyingNet Buying
NVS7.11%0.00%
AMGN78.37%1.00%Net SellingNet Selling
PFE64.30%0.27%Net Buying

Astrazeneca Stock Ownership FAQ

Who owns Astrazeneca?

Astrazeneca (NASDAQ: AZN) is owned by 32.60% institutional shareholders, 0.00% Astrazeneca insiders, and 67.40% retail investors. Price T Rowe Associates Inc is the largest individual Astrazeneca shareholder, owning 57.09M shares representing 3.68% of the company. Price T Rowe Associates Inc's Astrazeneca shares are currently valued at $4.10B.

If you're new to stock investing, here's how to buy Astrazeneca stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.